Corporate Responsibility KPIs

The following key performance indicators (KPIs) measure AbbVie’s programs and activities against our corporate responsibility commitments. All figures global unless noted otherwise.

Improve Health Outcomes

Target unmet needs to support patients and enhance access to healthcare across geographies.

Innovative Research
2014
2015
2016
Annual R&D investment (adjusted, in billions)
$3.25
$3.62
$4.15
Number of new product or indication approvals
2
4 7
Number of pro-bono hours by AbbVie scientists to research neglected diseases
13,529
17,148
21,583
       
Patient Support
2014
2015
2016
Number of patient impacts in AbbVie patient support programs globally
1,139,246
1,372,853
3,057,982
Number of active patient support programs globally
167
237
260
Number of U.S. patients provided medicine at no-cost through patient assistance programs
110,992
81,000
78,745
       
Capacity Building
2014
2015
2016
Number of countries receiving product donations following disasters, for medical missions or through planned donation programs
80
63
70
       
Medical Education
2014
2015
2016
Number of healthcare professionals impacted through innovative medical education programs
969,333
740,946
928,926
Number of patients impacted through innovative medical education programs
2,525,903
2,619,120
1,061,437
       

Operate Responsibly

Cultivate an ethical, transparent and inclusive culture to drive sustainable growth.

Healthy Environment
2014
2015
2016
By 2025 reduce absolute total CO2e emissions (Scope 1 & 2) by 25% (over a 2015 baseline) [1]
N/A
N/A
8%
By 2025 increase electricity purchased from renewable sources to 50% over a 2015 absolute baseline (excludes leased commercial offices) [1]
N/A
N/A
9%
By 2025 reduce absolute total water withdrawal (including non-contact cooling water) 20% over a 2015 baseline [1], [2]
N/A
N/A
4%+
By 2025 reduce absolute total amount of hazardous & non-hazardous waste generated by 20% (over a 2015 baseline) [1][3]
N/A
N/A
4%+
By 2025 achieve & maintain combined recycling rate of 50% for hazardous and non-hazardous waste over 2015 absolute baseline (excludes C&D waste)[1]
N/A
N/A
37%
CDP climate score [4]
83/C
89/D
A-
       
Sustainable Supply Chain
2014
2015
2016
Percent of top suppliers adhering to AbbVie sustainability requirements
30%
41%
62%
       
Quality & Safety
2014
2015
2016
Recordable incident rate (absolute)
0.39
0.23
0.27
Percent of medicine distributed without a drug shortage
99.9%
99.9%
99.9%
       
Ethical Culture
2014
2015
2016
Number of employees trained on our Code of Business Conduct [5]
16,564
21,960
28,580
       
Great Employer 2014
2015
2016
Female share of total workforce
52.6%
52.5%
52.9%
Females in top management (up to two levels away from CEO)
32.2%
33.7%
35%
Females in management positions (as % of total management workforce)
44.2%
44.2%
44.7%
New hires that were female (global)
N/A
N/A
55.7%
New hires that were underrepresented ethnic groups (U.S.)
N/A
N/A
39.2%
Employee engagement rate
78%
80%
81%
Number of Great Place to Work and Top Employer awards
N/A
N/A
28
       
Responsible Research
2014
2015
2016
Number of patients participating in our clinical trials
112,065
122,813
89,539
Number of countries with active clinical trials
N/A
47
57
       
abbvie-icon-hand-and-heart-blue

Contribute to Communities

Partner with our communities to address challenges of the underserved.

Transformative Education
2014
2015
2016
Number of students reached globally through education projects
4,152
5,815
9,107
       
Engaged Employees
2014
2015
2016
Number of employee volunteers
1,602
4,272
8,174
Number of hours volunteered by employees during work time
11,366
42,417
65,473
Percent of U.S. employees who participate in employee giving campaign
94%
92%
95%
       

[1] In 2016 AbbVie established new 2025 environmental targets
[2] Increased non-contact cooling water withdrawal at one facility due to higher than average seasonal temperatures
[3] Increased manufacturing increased waste volume
[4] In 2016 CDP scores changed to a single score (on a four-band scale A-D) 
[5] Figure fluctuates with workforce